Arrowhead Research | ARWR - Ebitda

Harga Saham
56.33
Perubahan Harian
-0.63 -1.11%
Bulanan
-10.79%
Tahunan
280.61%
Q1 Perkiraan
54.64




Ebitda Perubahan Tanggal
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Incyte USD 414.5M 92.42M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
Merck USD 8.39B 1.97B 2025-09
Moderna USD -790M 582M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 4.77B 1.11B 2025-12
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
TG Therapeutics USD 32.69M 5M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09
Xencor USD -51.05M 55.28M 2025-12